A young adult patient who needed extracorporeal membrane oxygenation after pericardiocentesis due to post-pericardiotomy syndrome

Article information

Pediatr Emerg Med J. 2026;13(1):33-39
Publication date (electronic) : 2025 December 8
doi : https://doi.org/10.22470/pemj.2025.01431
1Department of Pediatric Cardiology, Gachon University Gil Medical Center, Incheon, Republic of Korea
2Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
Corresponding author: Gi Beom Kim Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea Tel: +82-2-2072-0266; E-mail: ped9526@snu.ac.kr
Received 2025 August 27; Revised 2025 October 2; Accepted 2025 November 6.

Abstract

We report a 27-year-old woman who presented with orthopnea, which occurred after undergoing an open-heart surgery, atrial septal defect closure with mitral valve cleft repair. Pericardiocentesis was successfully performed; however, she subsequently developed circulatory collapse, necessitating the application of extracorporeal membrane oxygenation. Pericardial decompression syndrome is a potentially fatal complication, and clinicians should be aware of this risk when performing pericardiocentesis.

Introduction

Pericardial decompression syndrome (PDS) is a rare but life-threatening complication of pericardiocentesis or surgical pericardiostomy, leading to paradoxical hemodynamic collapse and ventricular dysfunction. First described in 1983 (1), its exact cause remains unknown (2,3). Our case highlights acute ventricular collapse after pericardiocentesis, emphasizing the need for vigilant monitoring to detect and manage hemodynamic instability.

Case

A 27-year-old woman presented with a 2-week history of dyspnea and orthopnea to the emergency department (ED) at her 2 months postoperatively. Four months before the presentation, a routine checkup led to an echocardiographic diagnosis of complete atrioventricular septal defect with persistent primum atrial septal defect and spontaneously closed ventricular septal defect. Subsequently, she underwent atrial septal defect closure and mitral valve cleft repair without complications. At 1-month follow-up, she was asymptomatic, prompting diuretic discontinuation. Transthoracic echocardiography showed normal left ventricular (LV) systolic function, preserved right ventricular (RV) systolic function, only mild tricuspid regurgitation, and no evidence of pulmonary hypertension.

At the ED, her initial vital signs were as follows: blood pressure (BP), 97/69 mmHg; heart rate (HR), 120 beats/minute; respiratory rate, 24 breaths/minute; temperature, 36.7 °C; and oxygen saturation, 93% on room air. Heart sounds were distant, jugular venous pressure was elevated, with no definite pulsus paradoxus noted. Initial chest radiography showed cardiomegaly while electrocardiography showed a low QRS voltage (Figure 1). Echocardiography confirmed a large pericardial effusion with respiratory phase variation (Figure 2). The maximum depth of the effusion was approximately 45 mm.

Fig. 1.

Initial chest radiograph showing a cardiothoracic ratio of 0.73 (A) and electrocardiogram showing a low QRS voltage (B).

Fig. 2.

Initial transthoracic echocardiogram showing the mitral valve inflow Doppler pattern variation among respiration obtained at the emergency department.

In the ED, an urgent echocardiography-guided pericardiocentesis was performed within 2 hours of presentation, draining 200 mL of serosanguineous fluid, of which the analysis showed no signs of infection. Following the procedure, her vital signs remained as follows: BP, 90/66 mmHg; HR, 124 beats/minute; and respiratory rate, 31 breaths/minute. The rate of the pericardial fluid drainage was maintained at 100 mL/hour, with dobutamine infused at 3 μg/kg/minute.

Twelve hours later, after 1,200 mL had been drained, her systolic BP and urine output dropped to 70 mmHg and 0 mL for the 12 hours, respectively, while HR remained at 128 beats/minute. She also had worsening dyspnea, cool extremities, and signs of peripheral hypoperfusion, while her mental status remained alert with no cyanosis noted. At the time these symptoms manifested, an echocardiography was performed, which demonstrated severe biventricular dysfunction: LV ejection fraction < 10%, global hypokinesia, RV enlargement, and severe tricuspid regurgitation.

Cardiogenic shock persisted despite the volume loading, metabolic correction, and inotropic support. Given her worsening condition, venoarterial extracorporeal membrane oxygenation (ECMO) was initiated with LV venting (Figure 3A). On day 7, ECMO was successfully weaned, with cardiac function fully recovered. A follow-up radiograph showed a normalized cardiac silhouette (Figure 3B). She was discharged on day 23 and remained in good health at her 2-year follow-up.

Fig. 3.

Chest radiographs at the time of initiation of extracorporeal membrane oxygenation and at discharge. A chest radiograph on day 2, showing the cannulas in place following their insertion for the extracorporeal membrane oxygenation (A). A follow-up radiograph on day 23 at the time of discharge (B). RA: right atrium, LV: left ventricle.

Discussion

PDS is a rare but life-threatening complication of pericardiocentesis or surgical pericardiotomy, causing biventricular dysfunction and cardiogenic shock. This paradoxical hemodynamic instability occurs unexpectedly after treatment of cardiac tamponade. Despite being recognized for decades, the exact cause remains unknown with proposed mechanisms involving both catheter-based and surgical drainage (4).

Several hypotheses explain its pathophysiology (5,6). First, the hemodynamic hypothesis suggests that rapid pericardial drainage for treating cardiac tamponade increases venous return and overloads the LV. At the same time, the elevated systemic vascular resistance induced by the tamponade may persist transiently even after pericardiocentesis, creating a functional state similar to the ongoing tamponade. Second, the ischemic hypothesis states that compression of the coronary arteries by pericardial fluid results in myocardial ischemia, which may persist even after relief of compression due to a stunned myocardium. Third, the sympathetic withdrawal hypothesis proposes that compensatory sympathetic activation in the tamponade maintains cardiac output, but after rapid fluid removal, loss of this stimulus leads to cardiac dysfunction and collapse. A single unifying mechanism has yet to be identified, suggesting multiple contributing factors (7).

Incidence of PDS is reported to be 5%-11% following surgical pericardial drainage, while data on catheter-based pericardiocentesis remain limited (8). Mortality rates range from 30% to 80%, with surgical drainage carrying a higher risk (9). However, it is challenging to interpret these findings due to confounding factors.

One key risk factor is the rate of pericardial effusion withdrawal. Studies suggest that rapid removal of pericardial fluid increases the risk of cardiogenic shock (10-12). The underlying etiology of the pericardial effusion also affects prognosis. Clinicians should assess cytologic analysis for malignancy and evaluate myocardial function for underlying coronary artery disease or myocarditis. Following clinical stabilization, it may require coronary angiography, myocardial perfusion imaging, or cardiac magnetic resonance imaging.

Our patient was diagnosed with a complete atrioventricular septal defect at the age of 27 years and underwent the open-heart surgical repair. She later developed progressive pericardial effusion due to post-pericardiotomy syndrome. Given the risk of cardiac tamponade, pericardiocentesis was performed.

Differential diagnosis should include myopericarditis or infectious pericarditis (13). When pericardial effusion coexists with acute hemodynamic deterioration and ventricular dysfunction, it is essential to exclude acute inflammatory or infectious etiologies before attributing the collapse to PDS. In our patient, pericardial fluid analysis showed no evidence of infection, and peri-procedural cardiac enzymes did not exhibit a rise suggestive of acute myocarditis (Figure 4). Moreover, there were no clinical or laboratory features of systemic infection. Taken together with the temporal context after the recent cardiac surgery, these findings supported post-pericardiotomy syndrome complicated by PDS, rather than newly developed myopericarditis. While a subclinical inflammatory process can never be completely excluded, the preponderance of evidence favored PDS on the background of post-pericardiotomy effusion.

Fig. 4.

Temporal pattern of cardiac enzymes relative to key events (vertical bars). ECMO: extracorporeal membrane oxygenation, CKMB: creatine kinase-MB fraction.

To mitigate hemodynamic instability, the drainage rate was carefully controlled. At present, no standardized guidelines define the optimal rate or maximum safe volume for pericardial fluid removal during pericardiocentesis. However, despite cautious fluid removal, PDS still occurred. In our case, there was no prompt hemodynamic recovery immediately after the pericardiocentesis. Rather, her vital signs remained stable but not fully normalized while infusing low-dose dobutamine. Pericardial fluid was removed gradually at 100 mL/hour. Approximately 12 hours later, after a cumulative 1,200 mL had been drained, she developed cardiogenic shock with anuria. Transthoracic echocardiography at that time demonstrated severe biventricular systolic dysfunction. This clinical trajectory, lack of immediate improvement followed by delayed hemodynamic deterioration, aligns more closely with PDS than with classic tamponade or uncomplicated post-pericardiotomy syndrome. RV dysfunction was the primary manifestation, affecting LV systolic and diastolic function. Despite gradual drainage, she developed PDS, which can present with paradoxical hemodynamic collapse even after apparently successful pericardial fluid removal.

Venoarterial ECMO played a crucial role in stabilizing the patient by supporting end-organ perfusion while awaiting cardiac recovery. On day 7, the ECMO was successfully weaned off, and LV function fully recovered. For patients with low cardiac output syndrome, ECMO can serve as a lifesaving treatment (14).

PDS-related LV dysfunction must be differentiated from stress-induced cardiomyopathy (SIC), which presents as transient LV dysfunction with apical ballooning during systole. SIC mimics acute coronary syndrome, particularly anterior myocardial infarction. The classic “Takotsubo” shape of the LV is typically observed in elderly women following stress. Recent studies report cases involving mid-ventricular segments, excluding the apex. Unlike PDS, SIC generally resolves within 1 month (15).

Currently, no standardized preventive strategies exist for PDS. However, the rate and volume of pericardial fluid removal appear to be key modifiable factors. Gradual and controlled drainage allows adaptive hemodynamic compensation, reducing the risk of abrupt circulatory collapse and acute pulmonary edema following pericardial drainage (16,17) (Appendix, https://doi.org/10.22470/pemj.2025.01431).

Despite careful drainage control in our case, PDS still occurred. This underscores the importance of early recognition, continuous monitoring, and hemodynamic assessment. Given its potential severity, clinicians should be prepared to implement maximum pharmacologic support and, if necessary, ECMO as a rescue therapy for severe hemodynamic instability.

PDS is a rare yet life-threatening complication that may develop following pericardiocentesis, with its etiology still unknown. Since clinicians cannot completely prevent PDS due to multiple complex factors, increasing awareness of PDS to facilitate early treatment decisions and improve prognosis would be a more favorable strategy.

Notes

Author contributions

Conceptualization, Data curation, Investigation, Supervision, and Validation: GB Kim

Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Software, and Visualization: KJ Ahn

Writing-original draft: KJ Ahn

Writing-review and editing: all authors

All authors read and approved the final manuscript.

Conflicts of interest

No potential conflicts of interest relevant to this article were reported.

Funding sources

No funding source relevant to this article was reported.

References

1. Vandyke WH Jr, Cure J, Chakko CS, Gheorghiade M. Pulmonary edema after pericardiocentesis for cardiac tamponade. N Engl J Med 1983;309:595–6.
2. Ligero C, Leta R, Bayes-Genis A. Transient biventricular dysfunction following pericardiocentesis. Eur J Heart Fail 2006;8:102–4.
3. Angouras DC, Dosios T. Pericardial decompression syndrome: a term for a well-defined but rather underreported complication of pericardial drainage. Ann Thorac Surg 2010;89:1702–3.
4. Imazio M. Pericardial decompression syndrome: a rare but potentially fatal complication of pericardial drainage to be recognized and prevented. Eur Heart J Acute Cardiovasc Care 2015;4:121–3.
5. Sobieski C, Herner M, Goyal N, Khor LL, Chang L, Bieging E, et al. Pericardial decompression syndrome after drainage of chronic pericardial effusions. JACC Case Rep 2022;4:1515–21.
6. Prabhakar Y, Goyal A, Khalid N, Sharma N, Nayyar R, Spodick DH, et al. Pericardial decompression syndrome: a comprehensive review. World J Cardiol 2019;11:282–91.
7. Dosios T, Theakos N, Angouras D, Asimacopoulos P. Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy. Chest 2003;124:242–6.
8. Chung J, Ocken L, Wolo E, Herman CR, Goldhammer JE. Acute right ventricular failure after surgical drainage of pericardial tamponade: a case report of pericardial decompression syndrome and review of the literature. J Cardiothorac Vasc Anesth 2019;33:768–71.
9. Pradhan R, Okabe T, Yoshida K, Angouras DC, DeCaro MV, Marhefka GD. Patient characteristics and predictors of mortality associated with pericardial decompression syndrome: a comprehensive analysis of published cases. Eur Heart J Acute Cardiovasc Care 2015;4:113–20.
10. Fozing T, Zouri N, Adam O, Oezbek C. Management of a patient with pericardial decompression syndrome and HOCM. BMJ Case Rep 2016;2016:bcr2015211550.
11. Karamichalis JM, Gursky A, Valaulikar G, Pate JW, Weiman DS. Acute pulmonary edema after pericardial drainage for cardiac tamponade. Ann Thorac Surg 2009;88:675–7.
12. Liao BT, Lo SS. Paradoxical hemodynamic collapse after subxiphoid pericardial window. A A Case Rep 2015;4:65–7.
13. Al Banna R, Husain A. Reversible severe biventricular dysfunction postpericardiocentesis for tuberculous pericardial tamponade. BMJ Case Reports 2011;2011:bcr0220113837.
14. Orban C, Borjog T, Talpau C, Agapie M, Bratu A, Jafal M, et al. The Jack-in-the-box: pericardial decompression syndrome managed by a multidisciplinary approach with early initiation of veno-Arterial extracorporeal membrane oxygenation: a case report. Medicina (Kaunas) 2024;60:1747.
15. Yoshikawa T. Takotsubo cardiomyopathy, a new concept of cardiomyopathy: clinical features and pathophysiology. Int J Cardiol 2015;182:297–303.
16. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J 2013;34:1186–97.
17. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015;36:2921–64.

Appendices

Appendix. Management proposal of PDS

Article information Continued

Fig. 1.

Initial chest radiograph showing a cardiothoracic ratio of 0.73 (A) and electrocardiogram showing a low QRS voltage (B).

Fig. 2.

Initial transthoracic echocardiogram showing the mitral valve inflow Doppler pattern variation among respiration obtained at the emergency department.

Fig. 3.

Chest radiographs at the time of initiation of extracorporeal membrane oxygenation and at discharge. A chest radiograph on day 2, showing the cannulas in place following their insertion for the extracorporeal membrane oxygenation (A). A follow-up radiograph on day 23 at the time of discharge (B). RA: right atrium, LV: left ventricle.

Fig. 4.

Temporal pattern of cardiac enzymes relative to key events (vertical bars). ECMO: extracorporeal membrane oxygenation, CKMB: creatine kinase-MB fraction.

Item Note
Clinical settings and timeframes PDS is an uncommon but potentially life-threatening complication that may follow pericardiocentesis or surgical drainage, particularly in patients with large or chronic effusions (often malignant), with postsurgical effusions, and with preexisting ventricular dysfunction or pericardial constriction physiology.
PDS typically manifests within the first 24 hours after decompression, although later presentations have been reported. The proposed mechanisms include a hemodynamic preload–afterload mismatch with acute RV dilation and septal shift, transient ischemia/stunned myocardium, and sympathetic withdrawal.
Post-drainage observation Given the risk window and potential for sudden deterioration, continuous monitored care (ICU/telemetry) is advisable for at least the first 24 hours after drainage, with extended observation in high-risk patients (e.g., large chronic effusions, malignancy, prior radiotherapy, depressed LVEF, or postsurgical effusions).
Bedside echocardiography to reassess ventricular size/function and valve regurgitation are valuable when symptoms or vital signs change.
Drainage strategy (rate and volume) There are no evidence-based standardized guidelines for a “safe” hourly rate or total volume.
A widely cited practical approach is staged, gradual decompression, removing only the amount necessary to reverse tamponade physiology, then leaving an indwelling drain for slow, controlled removal.
Expert sources recommend avoiding large single-session evacuations; the ESC guidance advises stepwise drainage with < 1 L per step and removing the catheter when daily return falls to approximately 25-50 mL (17).
Importantly, PDS has occurred even after small-volume (≈ 450 mL) drainage, underscoring that individualization and close hemodynamic/echo monitoring are more important than any fixed threshold.
Management once PDS develops Treatment is supportive and escalatory: optimize oxygenation and ventilation; judiciously manage preload (avoid both under- and over-filling), afterload, and contractility with vasoactive agents as needed; treat pulmonary edema; and use serial echocardiography to guide therapy.
In refractory shock, mechanical circulatory support (e.g., VA-ECMO) can be lifesaving while ventricular function recovers, as illustrated in our case.
Practical takeaway In patients with large or chronic effusions (especially postsurgical or malignant), plan for staged decompression, monitor continuously for at least 24 hours, and maintain a low threshold to escalate when early signs of RV failure or pulmonary edema appear.

PDS: pericardial decompression syndrome, RV: right ventricle, ICU: intensive care unit, LVEF: left ventricular ejection fraction, ESC: European Society of Cardiology, VA-ECMO: venoarterial extracorporeal membrane oxygenation.